Effect of Agent Orange Exposure on Endocrine Tumor Aggressiveness

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 11-005535
    • Jacksonville, Florida: 11-005535
    • Scottsdale/Phoenix, Arizona: 11-005535
    Sponsor Protocol Number: 11-005535

About this study

The intent is to collect relevant clinical data on patients exposed to Agent Orange plus assessment of the tissue for genetic mutations known to be associated with growth of thyroid cancer and pituitary tumors and report our findings as a descriptive case series.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Detailed Description:  No involvement of subjects will be needed other than granting permission for use of tissue from their surgical specimen. The thyroid tissue is collected under the standing MCF Thyroid Cancer Biorepository protocol (08-000922). Informed consent will be obtained for the two pituitary specimens under this present protocol.

Population:  Retrospective case series of patients who recently presented to the Mayo Clinic.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Victor Bernet, M.D.

Contact us for the latest status

Contact information:

Victor Bernet M.D.

(904)953-2224

Bernet.Victor@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Victor Bernet, M.D.

Contact us for the latest status

Contact information:

Victor Bernet M.D.

(904)953-2224

Bernet.Victor@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Victor Bernet, M.D.

Contact us for the latest status

Contact information:

Sydney Westphal M.D.

(480)301-8629

Westphal.Sydney@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20396722

Mayo Clinic Footer